MARKET

BNTX

BNTX

BIONTECH
NASDAQ
89.33
-2.73
-2.97%
After Hours: 91.00 +1.67 +1.87% 17:40 07/24 EDT
OPEN
92.00
PREV CLOSE
92.06
HIGH
92.19
LOW
88.92
VOLUME
886.02K
TURNOVER
--
52 WEEK HIGH
124.00
52 WEEK LOW
79.52
MARKET CAP
22.59B
P/E (TTM)
-15.2696
1D
5D
1M
3M
1Y
5Y
1D
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring
The Motley Fool · 1d ago
BioNTech: The Market Is Paying Too Much For An Unproven Pipeline
Seeking Alpha · 3d ago
Weekly Report: what happened at BNTX last week (0713-0717)?
Weekly Report · 4d ago
BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?
Simply Wall St · 5d ago
How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines
Simply Wall St · 07/18 01:23
Roivant unit Genevant, Arbutus file patent infringement suits against Pfizer, BioNTech over LNP technology
PUBT · 07/16 12:45
Arbutus, Genevant File International Lawsuits Against Pfizer, BioNTech
NASDAQ · 07/16 12:39
Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech
Dow Jones · 07/16 12:10
More
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Webull offers BioNTech SE - ADR stock information, including NASDAQ: BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.